Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
by on Tuesday, January 24th, 2012 | No Comments
Condition: Leukemia
Interventions: Drug: Cladribine; Drug: Cytarabine; Drug: Decitabine
Sponsor: M.D. Anderson Cancer Center
Not yet recruiting – verified January 2012
Read this article: Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)